530 related articles for article (PubMed ID: 1531063)
1. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
2. The cellular basis for lack of antibody response to hepatitis B vaccine in humans.
Egea E; Iglesias A; Salazar M; Morimoto C; Kruskall MS; Awdeh Z; Schlossman SF; Alper CA; Yunis EJ
J Exp Med; 1991 Mar; 173(3):531-8. PubMed ID: 1825504
[TBL] [Abstract][Full Text] [Related]
3. Genetic prediction of nonresponse to hepatitis B vaccine.
Alper CA; Kruskall MS; Marcus-Bagley D; Craven DE; Katz AJ; Brink SJ; Dienstag JL; Awdeh Z; Yunis EJ
N Engl J Med; 1989 Sep; 321(11):708-12. PubMed ID: 2528067
[TBL] [Abstract][Full Text] [Related]
4. The human immune response to hepatitis B surface antigen.
Alper CA
Exp Clin Immunogenet; 1995; 12(3):171-81. PubMed ID: 8534503
[TBL] [Abstract][Full Text] [Related]
5. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.
Craven DE; Awdeh ZL; Kunches LM; Yunis EJ; Dienstag JL; Werner BG; Polk BF; Syndman DR; Platt R; Crumpacker CS
Ann Intern Med; 1986 Sep; 105(3):356-60. PubMed ID: 2943202
[TBL] [Abstract][Full Text] [Related]
6. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype.
Alper CA; Marcus-Bagley D; Awdeh Z; Kruskall MS; Eisenbarth GS; Brink SJ; Katz AJ; Stein R; Bing DH; Yunis EJ; Schur PH
Tissue Antigens; 2000 Sep; 56(3):207-16. PubMed ID: 11034556
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients.
Stachowski J; Kramer J; Füst G; Maciejewski J; Baldamus CA; Petrányi GG
Scand J Immunol; 1995 Jul; 42(1):60-5. PubMed ID: 7631146
[TBL] [Abstract][Full Text] [Related]
8. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen.
Langö-Warensjö A; Cardell K; Lindblom B
Tissue Antigens; 1998 Oct; 52(4):374-80. PubMed ID: 9820601
[TBL] [Abstract][Full Text] [Related]
9. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
[TBL] [Abstract][Full Text] [Related]
10. Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells.
Watanabe H; Matsushita S; Kamikawaji N; Hirayama K; Okumura M; Sasazuki T
Hum Immunol; 1988 May; 22(1):9-17. PubMed ID: 2968966
[TBL] [Abstract][Full Text] [Related]
11. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype.
Hatae K; Kimura A; Okubo R; Watanabe H; Erlich HA; Ueda K; Nishimura Y; Sasazuki T
Eur J Immunol; 1992 Jul; 22(7):1899-905. PubMed ID: 1352502
[TBL] [Abstract][Full Text] [Related]
12. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells.
Watanabe H; Okumura M; Hirayama K; Sasazuki T
Tissue Antigens; 1990 Aug; 36(2):69-74. PubMed ID: 1702907
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.
Schroeder HW; Zhu ZB; March RE; Campbell RD; Berney SM; Nedospasov SA; Turetskaya RL; Atkinson TP; Go RC; Cooper MD; Volanakis JE
Mol Med; 1998 Feb; 4(2):72-86. PubMed ID: 9508785
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR2, [HLA-B7, SC31, DR2], and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy.
Blumenthal M; Marcus-Bagley D; Awdeh Z; Johnson B; Yunis EJ; Alper CA
J Immunol; 1992 Jan; 148(2):411-6. PubMed ID: 1729361
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
16. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.
Desombere I; Hauser P; Rossau R; Paradijs J; Leroux-Roels G
J Immunol; 1995 Jan; 154(2):520-9. PubMed ID: 7814865
[TBL] [Abstract][Full Text] [Related]
17. HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination.
Marescot MR; Budkowska A; Pillot J; Debre P
Tissue Antigens; 1989 May; 33(5):495-500. PubMed ID: 2477913
[TBL] [Abstract][Full Text] [Related]
18. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.
Caillat-Zucman S; Gimenez JJ; Wambergue F; Albouze G; Lebkiri B; Naret C; Moynot A; Jungers P; Bach JF
Kidney Int; 1998 Jun; 53(6):1626-30. PubMed ID: 9607193
[TBL] [Abstract][Full Text] [Related]
19. C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2.
Segurado OG; Giles CM; Iglesias-Casarrubios P; Corell A; Martinez-Laso J; Vicario JL; Arnaiz-Villena A
Immunobiology; 1991 Sep; 183(1-2):12-22. PubMed ID: 1682241
[TBL] [Abstract][Full Text] [Related]
20. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
Matsui Y; Alosco SM; Awdeh Z; Duquesnoy RJ; Page PL; Hartzman RJ; Alper CA; Yunis EJ
Immunogenetics; 1984; 20(6):623-31. PubMed ID: 6239824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
